Live Feed

Leading enrolling centers include Cleveland Clinic, three major campuses of the Mayo Clinic, Northwestern University, Massachusetts General Hospital, Columbia University–NewYork-Presbyterian, NYU Langone Health, Lenox Hill Hospital/Northwell Health, and Houston Methodist Hospital.Growing interest in MAVERIC is expected to support the activation of up to seven additional U.S. clinical centers, with the total number anticipated to reach 25.Patient enrollment surpassed 50% in early January and has now reached 75%.Target recruitment is anticipated by the end of Q2 2026, with the potential to extend into Q3 to accommodate patient enrollment from the additional clinical sites.MAVERIC builds on pos

Family-operated grocery retailer to host virtual hiring fair and community meet-and-greet ahead of openingLAKEWOOD, Colo., April 28, 2026 /PRNewswire/ -- Natural Grocers®, the nation's largest family-operated organic and natural grocery retailer, plans to open a new store in Rapid City, South Dakota, this summer. Located near downtown Rapid City at 855 Omaha St., Suite 300, the new store will mark Natural Grocers' second location in South Dakota, following its first store in Sioux Falls, which opened in 2022. NATURAL GROCERS AND RAPID CITYWith more than 70 years of experience se

Appointment strengthens Board with seasoned public company biotech executive following recent Nasdaq direct listingSARASOTA, Fla., April 28, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ:LABT), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class, today announced the appointment of Joseph Tucker, Ph.D., Chief Executive Officer of Enveric Biosciences (NASDAQ:ENVB), to its Board of Directors. Dr. Tucker's appointment follows Lakewood-Amedex Biotherapeutics' recent direct listing on Nasdaq and represents a key step in strengthening the Company's governance

SAN JOSE, Calif., April 28, 2026 /PRNewswire/ -- QuickLogic Corporation (NASDAQ:QUIK), a developer of embedded FPGA (eFPGA) Hard IP, Strategic Radiation Hardened and Antifuse FPGAs and ruggedized programmable logic solutions, today announced that it has scheduled a conference call to discuss its first quarter fiscal 2026 financial results on Tuesday, May 12, 2026. Date: Tuesday, May 12, 2026Time: 5:30 p.m. ET/2:30 p.m. PTDial-in: Toll Free: 1-877-407-0792; International: 1-201-689-8263Passcode: No passcode neededReplay: (844) 512-2921; Passcode: 13760179Duration: Through May 19,

PRINCETON, N.J., April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Data Monitoring Committee completed the interim efficacy analysis of its pivotal Phase 3 FLASH2 (Fluorescent Light Activated Synthetic Hypericin 2) trial evaluating HyBryte™ (Synthetic Hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL). Under the terms of the interim analysis, the study was recommended to halt for futility.   

For the first quarter of 2026, net income of $29.5 million, up 40% year-over-year Hope Bancorp, Inc. (the "Company" or "Hope") (NASDAQ:HOPE), the holding company of Bank of Hope (the "Bank"), today reported unaudited financial results for its first quarter ended March 31, 2026. For the three months ended March 31, 2026, the Company recorded net income of $29.5 million, or $0.23 per diluted common share, up 40% from net income of $21.1 million, or $0.17 per diluted common share, for the three months ended March 31, 2025, and down 14% from net income of $34.5 million, or $0.27 per diluted common share, for the three months ended December 31, 2025. For the three months ended March 31, 2026

Independent Director Brings More than 30 Years of Experience at Global Consumer Goods Companies lululemon athletica inc. (NASDAQ:LULU) today announced the appointment of Esi Eggleston Bracey, former Chief Growth & Marketing Officer of Unilever PLC, to its Board of Directors, effective immediately. With Ms. Bracey joining the Board, the company will have appointed six new independent directors in the last five years as part of the Board's commitment to continued refreshment. "Esi is a seasoned consumer and beauty industry executive whose career has combined brand creation, category transformation, global general management, and enterprise leadership across Unilever, Coty and Procter & Ga

Presentation at ASGCT Meeting will feature ICV as a routine neurosurgical procedure that provides broad biodistribution of gene therapy to the brain and nervous system Safety and efficacy of NGN-401 for Rett syndrome, delivered via ICV administration, to be highlighted Neurogene Inc. (NASDAQ:NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced an upcoming poster presentation that will demystify the intracerebroventricular (ICV) route of administration as a well-established, routinely performed neurosurgical procedure and a deliberate delivery strategy designed to maximize efficac

Hope Bancorp, Inc. (the "Company") (NASDAQ:HOPE) today announced that its Board of Directors declared a quarterly cash dividend of $0.14 per common share. The dividend is payable on or about May 22, 2026, to all stockholders of record as of the close of business on May 8, 2026. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ:HOPE) is the holding company for Bank of Hope, with $18.66 billion in total assets as of March 31, 2026. Following the addition of Territorial Savings as a division of Bank of Hope, the Company became the largest regional bank serving multicultural customers across the continental United States and Hawaii. Headquartered in Los Angeles, Bank of Hope offers a comp

Tamboran Resources Corporation plans to release the Company's third quarter earnings and operational update after NYSE market closes on Wednesday May 13, 2026 (US time). Tamboran's Chief Executive Officer, Mr. Todd Abbott will host a webcast commencing at 5:30pm EDT to provide an update on the Company's operations in the Beetaloo Basin. This will be followed by a short Q&A session with analysts. Access to the live audio webcast for the conference call is available via Tamboran's website at https://ir.tamboran.com/. A recording of the webcast will be available on the Tamboran Resources website following completion of the presentation. Time: 5:30pm EDT (New York) | 7:30am AEST (

Marks Sazmining's second U.S. deployment, with potential to scale subject to customer demand and capacity availability Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ:SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, today announced a partnership with Sazmining, a pioneer in Bitcoin Mining as a Service (BMaaS). The collaboration will support Sazmining's second U.S.-based mining operation with an initial 3 MW deployment at Soluna's Project Dorothy 1B. The partnership has the potential to scale over time, subject to customer demand and facility availability. This press release features multimedia. View the full release

MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- Watsco, Inc. (NYSE:WSO) today announced its operating results for the first quarter ended March 31, 2026. Watsco also announced that it has entered into an agreement to acquire Jackson Supply Company, one of the largest Sunbelt HVAC distributors, with annual sales of $230 million. The transaction is expected to close in the second quarter of 2026, pending completion of customary closing conditions. Following closing, Jackson Supply will continue to be led by its existing management team, in keeping with Watsco's long-standing approach of investing in great leaders and successful cultures. Watsco is the largest distributor in the highly fragmented

SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress taking place in Barcelona, Spain, from May 9–12, 2026. Eight presentations, including a late-breaking science oral presentation, are related to MYQORZO® (aficamten). Recently approved for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) by the U.S. Food and Drug Administration, European Commission, and the China National Medical Products Administration, MYQORZO is an allosteric and reversible inhibitor of cardiac myosin motor activity. In patients w

– ARCALYST® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $930 - $945 million –– KPL-387 Phase 2 recurrent pericarditis data expected in 2H 2026; Phase 3 pivotal trial expected to initiate by year-end –– Q1 2026 cash balance increased to $468.1 million – – Conference call and webcast scheduled for 8:30 am ET today – LONDON, April 28, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) (Kiniksa), a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications, today r

European commercial availability begins May 4, 2026, two months ahead of the previously targeted summer launchCertification expands the addressable market for the Company's flagship dental printing platform to over 60 million edentulous patients across the US and EU, representing a multi-billion dollar denture marketEarly feedback from the U.S. market launch highlights strong patient satisfaction with denture aesthetics, comfort, and performance using NextDent 300 technology ROCK HILL, S.C., April 28, 2026 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced that its NextDent® Jet Base and NextDent® Jet Teeth materials, together with the NextDent 300 MultiJet 3D printer, have receive

- New national campaign encourages recognition of ATTR-CM, often mistaken for other heart conditions, where earlier diagnosis and treatment may help improve outcomes1 PALO ALTO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) (the "Company," "we" or "BridgeBio"), a biopharmaceutical company focused on developing medicines for genetic conditions, has teamed up with award-winning actor Morgan Freeman and Howard "H" White, a longtime basketball apparel marketing executive, cultural connector, and heart health advocate, to bring greater attention to ATTR-CM, a progressive heart disease that can be underrecognized and often mistaken for other forms of heart fail

VANCOUVER, British Columbia, April 28, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (NASDAQ:ZENA) (FSE: 49Q) (BMV:ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces that its drone subsidiary ZenaDrone will mount its most comprehensive defense-focused presence to date at Xponential 2026, the flagship conference and exhibition of the Association for Uncrewed Vehicle Systems International (AUVSI), taking place May 11–14, 2026 in Detroit, Michigan. "Xponential is where the defense autonomous systems community convenes, and this year we are bringing an in-

NEWPORT BEACH, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. ("NorthStrive" or the "Company"), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) ("PMGC"), today announced the filing of a new U.S. patent application expanding its proprietary EL-22, a myostatin-engineered probiotic technology, into human pharmaceutical applications. The patent application (U.S. Application No. 19/655,160) covers the development of a formulated pharmaceutical product utilizing EL-22 for use in human patients suffering from muscle loss. The application includes protection for specific dosing regimens and formulations targeting a broad range of muscle-wasting conditions.

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE:SLG), Manhattan's largest office landlord, today announced that it has secured the asset management assignment to launch the leasing of 15 Laight Street, a 109,000 square foot, newly constructed boutique office building in Tribeca owned by the Hyundai Motor Group ("HMG"). In connection with an investment made through an affiliate of SL Green's $1.3 billion debt fund, the Company's third-party asset management platform, Green Property Services, has been engaged by HMG to provide comprehensive leasing and asset management services for the property. "Hyundai Motor Group is one of the world's great institutions, and this

ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026. Management will host 1x1 investor meetings that day. About Aveanna Healthcare Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 38 states providing a broad range of pediatric and adult healthcare services including nursing, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, home health and hospice services, as well a